, ,
Presentations this author is a contributor to:
How achievable is target HbA1c in insulin-treated type 2 diabetes (T2DM)? A multicentre study of 2025 patients from 8 specialist endocrine practices, including relationship of control to treatment centre and pattern of insulin administration (#275)
1:30 PM
David M Hoffman
ADS Clinical Poster Session
Gender differences in skeletal muscle sphingolipid and diacylglycerol content of insulin-sensitive and insulin-resistant humans (#133)
5:00 PM
Dorit Samocha-Bonet
ADS Clinical Orals - Diabetes and other insulin resistant states
Relationship between circulating Fatty Acid Binding Protein-4 (FABP4), subcutaneous and visceral adiposity, and insulin sensitivity in overweight and obese humans. (#132)
4:45 PM
Katherine T Tonks
ADS Clinical Orals - Diabetes and other insulin resistant states